References
- Hudak ML , Tan RC , COMMITTEE ON DRUGS, et al. Neonatal drug withdrawal. Pediatrics. 2012;129(2):e540–e560.
- SAMHSA-HRSA Center for Integrated Health Solutions . SBIRT: screening, brief intervention and referral to treatment. Washington, DC. [cited 2018 Sep 8]. Available from: https://www.integration.samhsa.gov/clinical-practice/SBIRT.
- NIDA . Resource guide: screening for drug use in general medical settings. National Institute on Drug Abuse website. March 2, 2012. [cited 2018 Sep 8]. Available from: https://www.drugabuse.gove/publications/resource-guide-screening-drug-use-in-general-medical-settings
- American College of Obstetricians and Gynecologists . Committee Opinion No. 711: opioid use and opioid use disorder in pregnancy. Obstet Gynecol. 2017;130(2):e81–e94.
- SAMHSA . Coding for screening and brief intervention reimbursement. Substance Abuse and Mental Health Services Administration website. September 15, 2017. [cited 2018 Nov 6]. Available from: https://www.samhsa.gov/sbirt/coding-reimbursement
- Yonkers KA , Gotman N , Kershaw T , et al. Screening for prenatal substance use: development of the Substance Use Risk Profile-Pregnancy scale. Obstet Gynecol. 2010;116(4):827–833.
- Roberts SC , Nuru-Jeter A. Women’s perspectives on screening for alcohol and drug use in prenatal care. Womens Health Issues. 2010;20(3):193–200.
- Kennedy C , Finkelstein N , Hutchins E , et al. Improving screening for alcohol use during pregnancy: the Massachusetts ASAP program. Matern Child Health J. 2004;8(3):137–147.
- Svikis D , Henningfield J , Gazaway P , et al. Tobacco use for identifying pregnant women at risk of substance abuse. J Reprod Med. 1997;42(5):299–302.
- Karunakaran P. Infants with neonatal abstinence syndrome and their drug dependent mothers compared to matched controls: we have a drug problem. Abstract presentation, American Academy of Pediatrics National Conference, Chicago, IL; 2017 September 15.
- Ko JY , Wolicki S , Barfield WD , et al. CDC grand rounds: public health strategies to prevent neonatal abstinence syndrome. Morb Mortal Wkly Rep. 2017;66(9):242–245.
- Murphy-Oikonen J , Montelpare WJ , Southon S , et al. Identifying infants at risk for neonatal abstinence syndrome: a retrospective cohort comparison study of 3 screening approaches. J Perinat Neonat Nurs. 2010;24(4):366–372.
- Klawans MR , Northrup TF , Villarreal YR , et al. A comparison of common practices for identifying substance use during pregnancy in obstetric clinics. Birth. [cited 2019 Mar 27]. DOI:10.1111/birt.12426
- Wexelblatt SL , Ward LP , Torok K , et al. Universal maternal drug testing in a high-prevalence region of prescription opiate abuse. J Pediatr. 2015;166(3):582–586.
- Cotten SW. Drug testing in the neonate. Clin Lab Med. 2012;32(3):449–466.
- Colby JM , Cotton SW. Facing challenges in neonatal drug testing. Washington, DC: American Association of Clinical Chemistry; March 1, 2018. [cited 2018 Nov 6]. Available from: https://www.aacc.org/publications/cln/articles/2018/march/facing-challenges-in-neonatal-drug-testing
- Montgomery DP , Plate CA , Jones M , et al. Using umbilical cord tissue to detect fetal exposure to illicit drugs: a multicentered study in Utah and New Jersey. J Perinatol. 2008;28(11):750–753.
- Palmer KL , Wood KE , Krasowski MD. Evaluating a switch from meconium to umbilical cord tissue for newborn drug testing: a retrospective study at an academic medical center. Clin Biochem. 2017;50(6):255–261.
- Colby JM. Comparison of umbilical cord tissue and meconium for the confirmation of in utero drug exposure. Clin Biochem. 2017;50(13–14):784–790.
- Lozano J , García-Algar O , Vall O , et al. Biological matrices for the evaluation of in utero exposure to drugs of abuse. Ther Drug Monit. 2007;29(6):711–734.
- de Castro A , Jones HE , Johnson RE , et al. Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes. Ther Drug Monit. 2011;33(4):443–452.
- Tzatzarakis MN , Alegakis AK , Kavvalakis MP , et al. Comparative evaluation of drug deposition in hair samples collected from different anatomical body sites. J Anal Toxicol. 2017;41(3):214–223.
- Gottås A , Øiestad EL , Boix F , et al. Levels of heroin and its metabolites in blood and brain extracellular fluid after i.v. heroin administration to freely moving rats. Br J Pharmacol. 2013;170(3):546–556.
- Mayo Clinic . Drug testing: opiates. Mayo Medical Laboratories. [cited 2017 Aug 3]. Available from: https://www.mayomedicallaboratories.com/test-info/drug-book/opiates.html
- Rook EJ , Huitema AD , van den Brink W , et al. Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature. Curr Clin Pharmacol. 2006;1(1):109–118.
- Milone MC. Laboratory testing for prescription opioids. J Med Toxicol. 2012;8(4):408–416.
- Kukko H , Halmesmäki E. Prenatal care and counseling of female drug-abusers: effects on drug abuse and perinatal outcome. Acta Obstet Gynecol Scand. 1999;78(1):22–26.
- Almario CV , Seligman NS , Dysart KC , et al. Risk factors for preterm birth among opiate-addicted gravid women in a methadone treatment program. Am J Obstet Gynecol. 2009;201(3):326.e1–326.e6
- Sword W , Niccols A , Fan A. “New Choices” for women with addictions: perceptions of program participants. BMC Public Health. 2004;4(10):10.
- Jessup MA , Humphreys JC , Brindis CD , et al. Extrinsic barriers to substance abuse treatment among pregnant drug dependent women. J Drug Issues. 2003;33(2):285–304
- Patrick SW , Schiff DM , Committee on Substance Use and Prevention . A public health response to opioid use in pregnancy. Pediatrics. 2017;139(3):1–7.
- Phillips D , Thomas K , Cox H , et al. Factors that influence women’s disclosures of substance use during pregnancy: a qualitative study of ten midwives and ten pregnant women. J Drug Issues. 2007;37(2):357–375
- Leading Experts in Women’s Health Care, Pediatrics & Addiction Medicine . Pregnant women with substance use disorders need health care, not incarceration. Statement released; January 19, 2018. [cited 2018 Oct 30]. Available from: https://www.acog.org/About-ACOG/News-Room/Statements/2018/Pregnant-Women-with-Substance-Use-Disorders-Need-Health-Care-Not-Incarceration
- Guttmacher Inst . Substance abuse during pregnancy; October 1, 2018. [cited 2018 Oct 30]. Available from: https://www.guttmacher.org/state-policy/explore/substance-abuse-during-pregnancy
- ASAM Board of Directors . Public Policy Statement on Substance Use, misuse and use disorders during and following pregnancy, with an emphasis on opioids. American Society of Addiction Medicine; January 18, 2017. [cited 2018 Oct 30]. Available from: https://www.asam.org/docs/default-source/public-policy-statements/substance-use-misuse-and-use-disorders-during-and-following-pregnancy.pdf
- Stone R. Pregnant women and substance use: fear, stigma, and barriers to care. Health Justice. 2015;3(1):1–15
- Angelotta C , Appelbaum PS. Criminal charges for child harm from substance use in pregnancy. J Am Acad Psychiatry Law. 2017;45(2):193–203.
- Milliren CE , Gupta M , Graham DA , et al. Hospital variation in neonatal abstinence syndrome incidence, treatment modalities, resource use, and costs across pediatric hospitals in the United States, 2013 to 2016. Hosp Pediatr. 2018;8(1):15–20.